FDMT
4D Molecular Therapeutics Inc

1,260
Mkt Cap
$476.92M
Volume
685,104.00
52W High
$12.34
52W Low
$2.24
PE Ratio
-2.38
FDMT Fundamentals
Price
$9.35
Prev Close
$9.36
Open
$9.39
50D MA
$8.81
Beta
1.30
Avg. Volume
781,019.35
EPS (Annual)
-$2.98
P/B
1.19
Rev/Employee
$163.00
$99.80
Loading...
Loading...
News
all
press releases
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the ten ratings firms that are currently covering the stock...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Short Interest Update
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totaling 8,677,770 shares, an...
MarketBeat·1mo ago
News Placeholder
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eleven ratings firms that are presently covering the stock...
MarketBeat·1mo ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Insider Scott Bizily Sells 1,635 Shares
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) insider Scott Bizily sold 1,635 shares of the stock in a transaction dated Tuesday, December 16th. The shares were sold at an average...
MarketBeat·2mo ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down - What's Next?
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down - What's Next...
MarketBeat·2mo ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Down 4.2% - Here's What Happened
4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 4.2% - Should You Sell...
MarketBeat·2mo ago
News Placeholder
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eleven analysts that are currently covering the stock...
MarketBeat·2mo ago
News Placeholder
Redmile Group LLC Cuts Stake in 4D Molecular Therapeutics, Inc. $FDMT
Redmile Group LLC trimmed its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) by 88.8% during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·2mo ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 5.3% - Here's Why
4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Down 5.3% - Should You Sell...
MarketBeat·2mo ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of 4D Molecular Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest FDMT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.